EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Cancer
NCT ID: NCT06083324
Last Updated: 2025-02-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2023-02-03
2026-01-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer
NCT06115486
Progressive Resistance Training for the Improvement of Physical Function
NCT04247425
Rapid Easy Strength Training (REST) to Improve Function in Late Stage Cancer
NCT01334983
Lung Cancer, Exercise and Force Development
NCT05778136
Blood Flow Restriction Exercise in Patients With Pancreatic, Biliary Tract, and Liver Cancer (PREV-Ex)
NCT05044065
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
General cancer patients
All patients undergoing treatment for cancer on an exercise regimen
Dose escalated resistance training
All individuals will be engaging in resistance training during and/or after their cancer treatment
Head and neck cancer patients
All patients undergoing treatment for head and neck cancer on an exercise regime
Dose escalated resistance training
All individuals will be engaging in resistance training during and/or after their cancer treatment
Colorectal cancer patients
All patients undergoing treatment for colorectal cancer on an exercise regime
Dose escalated resistance training
All individuals will be engaging in resistance training during and/or after their cancer treatment
Pancreatic cancer patients
All patients undergoing treatment for pancreatic cancer on an exercise regime
Dose escalated resistance training
All individuals will be engaging in resistance training during and/or after their cancer treatment
Metastatic breast cancer patients
All patients undergoing treatment for metastatic breast cancer on an exercise regime
Dose escalated resistance training
All individuals will be engaging in resistance training during and/or after their cancer treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dose escalated resistance training
All individuals will be engaging in resistance training during and/or after their cancer treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Women of child-bearing potential must verbally confirm lack of pregnancy prior to enrollment. They should also consent to use adequate contraception during the course of the study.
3. Participants must be determined capable of engaging in resistance training by exercise personnel and/or study PI
4. Participants must complete an assessment by EOC staff and be determined safe to engage in the workout regimen by the study exercise personnel.
5. Individuals not deemed safe to participate in the standard EOC exercise program will be referred to physical therapy or elsewhere
Exclusion Criteria
20 Years
89 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Colin Champ, MD
Radiation Oncologist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AHN CI Exercise Oncology and Resiliency Center
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Champ CE, Carpenter DJ, Diaz AK, Rosenberg J, Ackerson BG, Hyde PN. Resistance Training for Patients with Cancer: A Conceptual Framework for Maximizing Strength, Power, Functional Mobility, and Body Composition to Optimize Health and Outcomes. Sports Med. 2023 Jan;53(1):75-89. doi: 10.1007/s40279-022-01759-z. Epub 2022 Sep 29.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-021-SG
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.